Compare · ACON vs CNC
ACON vs CNC
Side-by-side comparison of Aclarion Inc. (ACON) and Centene Corporation (CNC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ACON and CNC operate in Medical Specialities (Health Care), so they compete in similar markets.
- CNC is the larger of the two at $32.49B, about 5762.1x ACON ($5.6M).
- Over the past year, ACON is down 68.9% and CNC is up 160.4% - CNC leads by 229.3 points.
- CNC has been more active in the news (9 items in the past 4 weeks vs 4 for ACON).
- CNC has more recent analyst coverage (25 ratings vs 0 for ACON).
- Company
- Aclarion Inc.
- Centene Corporation
- Price
- $2.26-3.83%
- $65.75+2.43%
- Market cap
- $5.6M
- $32.49B
- 1M return
- -22.34%
- -2.73%
- 1Y return
- -68.87%
- +160.42%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2022
- News (4w)
- 4
- 9
- Recent ratings
- 0
- 25
Aclarion Inc.
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
Centene Corporation
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members in the Managed Care segment. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; and vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Latest ACON
- SEC Form 10-Q filed by Aclarion Inc.
- Aclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology
- Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026
- Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice
- SEC Form S-8 filed by Aclarion Inc.
- Aclarion Announces Texas Spine Care Center as New CLARITY Site
- Chief Strategy Officer Bond Ryan was granted 55,000 shares (SEC Form 4)
- Executive Chairman Thramann Jeffrey John was granted 100,000 shares (SEC Form 4)
- Chief Financial Officer Gould Gregory A was granted 50,000 shares (SEC Form 4)
- Director Sequira Amanda Mae was granted 20,000 shares (SEC Form 4)
Latest CNC
- Superior HealthPlan and Centene Foundation Make $350,000 Investment to Help with Flood Relief in Texas
- Centene Corporation filed SEC Form 8-K: Other Events
- Director Diaz Paul J was granted 2,771 shares (SEC Form 4)
- New insider Diaz Paul J claimed no ownership of stock in the company (SEC Form 3)
- SEC Form 10-Q filed by Centene Corporation
- Centene Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- CENTENE CORPORATION REPORTS SECOND QUARTER 2026 RESULTS
- CENTENE ANNOUNCES BOARD OF DIRECTORS CHANGES
- Director Tyler Lauren M was granted 3,155 shares, increasing direct ownership by 5,172% to 3,216 units (SEC Form 4)
- CENTENE CORPORATION TO HOST 2026 SECOND QUARTER FINANCIAL RESULTS EARNINGS CALL